Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated May 26, 2022
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antares Pharma, Inc.
| -2.86M |
$5.60 | -$16,029,770.40 | -100.00% |
0
|
May 24
| |||||||
Antares Pharma, Inc.
| 49.12K |
$3.80 | -$143,241.00 | +2.01% | 2.49M |
Mar 3
| |||||||
Antares Pharma, Inc.
| 42.61K |
$3.66 | -$125,472.12 | +1.78% | 2.44M |
Feb 16
| |||||||
Antares Pharma, Inc.
| 149.66K |
$4.44 | $658,520.93 | +6.66% | 2.4M |
Jun 10 - Jun 13
| |||||||
Antares Pharma, Inc.
| -44.22K |
$4.39 | -$194,138.97 | -1.93% | 2.25M |
Jun 8
| |||||||
Antares Pharma, Inc.
| 86.43K |
$4.50 | -$298,485.00 | +3.92% | 2.29M |
Mar 1
| |||||||
Antares Pharma, Inc.
| -90.39K |
$2.94 | -$2,801,894.40 | -3.94% | 2.2M |
Feb 17 - Feb 18
|
Scheduled
| ||||||
Antares Pharma, Inc.
|
0
|
$3.69 | -$191,659.53 |
—
| 2.3M |
Feb 8 - Feb 10
|
Scheduled
| ||||||
Antares Pharma, Inc.
| 362.04K |
$2.76 | $986,319.14 | +18.73% | 2.3M |
Jun 11 - Jun 13
| |||||||
Antares Pharma, Inc.
| -93.16K |
$3.12 | -$291,098.31 | -4.60% | 1.93M |
Jun 7 - Jun 8
| |||||||
Antares Pharma, Inc.
| 120.39K |
$3.53 | -$319,101.41 | +6.32% | 2.03M |
Feb 19
| |||||||
Antares Pharma, Inc.
|
0
|
$3.52 | -$830,640.26 |
—
| 1.91M |
Dec 9 - Dec 10
| |||||||
Antares Pharma, Inc.
| 56.55K |
$2.44 | -$53,787.65 | +3.06% | 1.91M |
Nov 11
| |||||||
Antares Pharma, Inc.
| 282.53K |
$2.92 | $824,999.28 | +18.03% | 1.85M |
Jun 13
| |||||||
Antares Pharma, Inc.
| -93.16K |
$2.81 | -$261,782.41 | -5.61% | 1.57M |
Jun 7 - Jun 8
| |||||||
Antares Pharma, Inc.
| -52.56K |
$2.79 | -$146,639.61 | -3.07% | 1.66M |
Jun 2
| |||||||
Antares Pharma, Inc.
| 181.96K |
$3.20 | -$231,184.00 | +11.89% | 1.71M |
Feb 20
| |||||||
Antares Pharma, Inc.
|
0
|
$2.11 | -$141,040.00 |
—
| 1.53M |
Aug 21
|
Scheduled
| ||||||
Antares Pharma, Inc.
| 273.52K |
$2.70 | $738,517.50 | +21.76% | 1.53M |
Jun 7 - Jun 8
| |||||||
Antares Pharma, Inc.
| -34.40K |
$2.69 | -$92,541.38 | -2.66% | 1.26M |
Jun 2
| |||||||
Antares Pharma, Inc.
| -13.48K |
$2.43 | -$32,756.40 | -1.03% | 1.29M |
May 28
| |||||||
Antares Pharma, Inc.
| 52.45K |
$1.69 | -$5,606.04 | +4.19% | 1.3M |
May 11
| |||||||
Antares Pharma, Inc.
| 76.83K |
$2.20 | -$81,402.20 | +6.54% | 1.25M |
Feb 22
| |||||||
Antares Pharma, Inc.
| 338.12K |
$2.66 | $899,385.90 | +40.37% | 1.18M |
Jun 7
| |||||||
Antares Pharma, Inc.
| -390.59K |
$2.64 | -$1,047,227.02 | -43.89% | 1.18M |
Feb 22 - Jun 7
| |||||||
Antares Pharma, Inc.
|
0
|
$2.33 | -$54,070.30 |
—
| 890K |
Apr 4 - Apr 5
|
Scheduled
| ||||||
Antares Pharma, Inc.
| 20.28K |
$1.79 | -$19,534.95 | +2.33% | 890K |
Dec 27 - Dec 27
| |||||||
Antares Pharma, Inc.
| 11.22K |
$1.05 | $11,784.15 | +1.31% | 869.72K |
Jun 30
| |||||||
Antares Pharma, Inc.
| 363.15K |
$1.12 | $406,728.00 | +73.31% | 858.5K |
Jun 2
| |||||||
Antares Pharma, Inc.
| -21.82K |
$0.91 | -$19,861.00 | -4.22% | 495.35K |
May 31
| |||||||
Antares Pharma, Inc.
| 60K |
$0.72 | $43,200.00 | +13.12% | 517.16K |
Mar 18
| |||||||
Antares Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 10
| |||||||
Antares Pharma, Inc.
| 135.38K |
$2.14 | -$14,792.62 | +42.07% | 457.16K |
May 21 - May 28
| |||||||
Antares Pharma, Inc.
| 4.21K |
$2.67 | -$21,750.66 | +0.61% | 695.85K |
May 21 - Feb 10
| |||||||
Antares Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 10
| |||||||
Antares Pharma, Inc.
| 7.74K |
$2.36 | -$11,278.44 | +2.43% | 326.62K |
Feb 10
| |||||||
Antares Pharma, Inc.
| 97.09K |
—
|
—
| +28.23% | 441K |
May 29
| |||||||
Antares Pharma, Inc.
| -25.00K |
$4.45 | -$50,000.20 | -6.78% | 343.92K |
Feb 11
| |||||||
Antares Pharma, Inc.
|
0
|
$2.74 | -$45,300.00 |
—
| 368.92K |
Jan 10
|
Scheduled
| ||||||
Antares Pharma, Inc.
|
0
|
$2.76 | -$100,859.00 |
—
| 368.92K |
Oct 14
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.